Nabsys, a Providence, RI-based electronic whole-genome mapping company, raised $13M in funding.
This part of the round, with an expanded equity round now totaling $38M, was led by Hitachi High-Tech.
The company intends to use the funds to accelerate growth, expand operations and team.
Led by founder and CEO Barrett Bready, M.D., Nabsys is advancing and will offer a High-Definition Genome Mapping Platform through an early access program in the first half of 2023. Its mission is to advance the understanding of disease, increase diagnostic yield, and improve patient outcomes by enabling routine, accurate, cost-effective analysis of genomic structural variation. Located in Providence, Nabsys employs an interdisciplinary group of dedicated scientists, engineers, and other professionals committed to the advancement of genomic analysis.
FinSMEs
10/11/2022